Patents by Inventor Trent Martin Woodruff

Trent Martin Woodruff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS
    Publication number: 20140329761
    Abstract: The present invention relates generally to methods for the prevention and treatment of acute inflammatory conditions in individuals using an agonist of the complement C3a receptor.
    Type: Application
    Filed: June 20, 2012
    Publication date: November 6, 2014
    Applicant: The University of Queensland
    Inventors: Trent Martin Woodruff, Stephen Maxwell Taylor
  • TREATMENT OF NEUROLOGICAL CONDITIONS USING COMPLEMENT C5a RECEPTOR MODULATORS
    Publication number: 20090227492
    Abstract: This invention relates to the treatment of neurological conditions with novel cyclic peptidic and peptidomimetic compounds which have the ability to modulate the activity of C5a receptors. The compounds preferably act as antagonists of the C5a receptor, and are active against C5a receptors on polymorphonuclear leukocytes, monocytes, lymphocytes and/or macrophages. In a preferred form of the invention the neurological conditions are neurodegenerative diseases, neuroimmunological disorders, diseases arising from dysfunction of the blood brain barrier, and stroke.
    Type: Application
    Filed: April 15, 2009
    Publication date: September 10, 2009
    Inventors: Trent Martin WOODRUFF, Stephen Maxwell Taylor
  • METHODS FOR TREATING AND AMELIORATING THE SYMPTONS OF INFLAMMATORY BOWEL DISEASES
    Publication number: 20090004264
    Abstract: This invention relates to methods of treatment of inflammatory bowel disease, and especially to treatment of this condition with cyclic peptidic and peptidomimetic compounds which have the ability to modulate the activity of G protein-coupled receptors. The compounds preferably act as antagonists of the C5a receptor, and are active against C5a receptors on polymorphonuclear leukocytes and macrophages. Particularly preferred compounds for use in the methods of the invention are disclosed.
    Type: Application
    Filed: June 23, 2008
    Publication date: January 1, 2009
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Trent Martin Woodruff, Stephen Maxwell Taylor, David Fairlie
  • Treatment of inflammatory bowel disease
    Patent number: 7410945
    Abstract: This invention relates to methods of treatment of inflammatory bowel disease, and especially to treatment of this condition with cyclic peptidic and peptidomimetic compounds which have the ability to modulate the activity of G protein-coupled receptors. The compounds preferably act as antagonists of the C5a receptor, and are active against C5a receptors on polymorphonuclear leukocytes and macrophages. Particularly preferred compounds for use in the methods of the invention are disclosed.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: August 12, 2008
    Assignee: The University of Queensland
    Inventors: Trent Martin Woodruff, Stephen Maxwell Taylor, David Fairlie
  • Treatment of Neurological Conditions Using Complement C5a Receptor Modulators
    Publication number: 20080113904
    Abstract: This invention relates to the treatment of neurological conditions with novel cyclic peptidic and peptidomimetic compounds which have the ability to modulate the activity of C5a receptors. The compounds preferably act as antagonists of the C5a receptor, and are active against C5a receptors on polymorphonuclear leukocytes, monocytes, lymphocytes and/or macrophages. In a preferred form of the invention the neurological conditions are neurodegenerative diseases, neuroimmunological disorders, diseases arising from dysfunction of the blood brain barrier, and stroke.
    Type: Application
    Filed: March 21, 2005
    Publication date: May 15, 2008
    Inventors: Trent Martin Woodruff, Stephen Maxwell Taylor